US 7951817
Pyridomorphinans, pyridazinomorphinans and use thereof
granted A61PA61P25/00A61P25/04
Quick answer
US patent 7951817 (Pyridomorphinans, pyridazinomorphinans and use thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P25/00, A61P25/04, A61P25/30, A61P25/36